Inventor · disambiguated record
Noreen Tasneem Zaman
Also filed as: ZAMAN NOREEN · ZAMAN NOREEN TASNEEM
1 granted patent·10 pending applications·71 citations·filing 2011–2025
53Inventor score
Top patents by PatentIndex Score
11 records- 0191US8563593B2Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideALARGOVA ROSSITZA GUEORGUIEVA·Filed 2011·Granted Oct 22, 2013·71 cites·34 claims
- 0258US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 0358US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 0457US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 0557US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 0656US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 0752US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 0851US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 0949US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 1048US2014094499A1Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1144US2025270231A1Ulotaront hydrochloride manufacturing processSUMITOMO PHARMA AMERICA INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Noreen Tasneem Zaman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →